Skip to main content
. Author manuscript; available in PMC: 2018 Jul 15.
Published in final edited form as: Cancer Res. 2017 May 4;77(14):3745–3757. doi: 10.1158/0008-5472.CAN-16-1768

Figure 5. Knockdown of Orilnc1 expression reduces cancer cell growth in vitro and in vivo.

Figure 5

A. Relative expression of Orilnc1 in cells expressing control and Orilnc1 shRNAs in a panel of melanoma cell lines and a non-melanoma cancer cell, MDA-MB-231 (Breast; KRASG13D). B. Growth curves of cancer cell lines transfected with control or Orilnc1 shRNAs. C. Soft-agar assay with cells expressing control and Orilnc1 shRNAs. D. In vivo xenograft tumor growth curves of MDA-MB-231 (upper panel) and 1205Lu (lower panel) cells expressing control and Orilnc1 shRNAs.